{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:22:45Z","timestamp":1791296565779,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,9,2]],"date-time":"2011-09-02T00:00:00Z","timestamp":1314921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,9,2]],"date-time":"2011-09-02T00:00:00Z","timestamp":1314921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1038\/leu.2011.232","type":"journal-article","created":{"date-parts":[[2011,9,2]],"date-time":"2011-09-02T08:59:09Z","timestamp":1314953949000},"page":"542-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":184,"title":["SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts"],"prefix":"10.1038","volume":"26","author":[{"given":"V","family":"Visconte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Makishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Szpurka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Traina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Jerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Sekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R V","family":"Tiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,2]]},"reference":[{"key":"BFleu2011232_CR1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3324\/haematol.2011.044628","volume":"96","author":"M Cazzola","year":"2011","unstructured":"Cazzola M, Invernizzi R . Ring sideroblasts and sideroblastic anemias. Haematologica 2011; 96: 789\u2013792.","journal-title":"Haematologica"},{"key":"BFleu2011232_CR2","first-page":"96","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"RP Hasserjian","year":"2008","unstructured":"Hasserjian RP, Gatterman N, Bennett JM, Brunning RD, Thiele J . Refractory anemia with ring sideroblasts. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th edn. IARC: Lyon, France, 2008, pp 96\u201397."},{"key":"BFleu2011232_CR3","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1200\/JCO.2009.27.1361","volume":"28","author":"A Kohlmann","year":"2010","unstructured":"Kohlmann A, Grossmann V, Klein HU, Schindela S, Weiss T, Kazak B et al. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J Clin Oncol 2010; 28: 3858\u20133865.","journal-title":"J Clin Oncol"},{"key":"BFleu2011232_CR4","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood-2006-02-005751","volume":"108","author":"H Szpurka","year":"2006","unstructured":"Szpurka H, Tiu R, Murugesan G, Aboudola S, Hsi ED, Theil KS et al. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation. Blood 2006; 108: 2173\u20132181.","journal-title":"Blood"},{"key":"BFleu2011232_CR5","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/sj.leu.2404316","volume":"20","author":"SA Wang","year":"2006","unstructured":"Wang SA, Hasserjian RP, Loew JM, Sechman EV, Jones D, Hao S et al. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features. Leukemia 2006; 20: 1641\u20131644.","journal-title":"Leukemia"},{"key":"BFleu2011232_CR6","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1182\/blood-2006-03-008227","volume":"108","author":"M Boissinot","year":"2006","unstructured":"Boissinot M, Garand R, Hamidou M, Hermouet S . The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS). Blood 2006; 108: 1781\u20131782.","journal-title":"Blood"},{"key":"BFleu2011232_CR7","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1038\/sj.leu.2404405","volume":"20","author":"A Renneville","year":"2006","unstructured":"Renneville A, Quesnel B, Charpentier A, Terriou L, Crinquette A, Lai JL et al. High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Leukemia 2006; 20: 2067\u20132070.","journal-title":"Leukemia"},{"key":"BFleu2011232_CR8","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1182\/blood-2006-05-022491","volume":"109","author":"N Gattermann","year":"2007","unstructured":"Gattermann N, Billiet J, Kronenwett R, Zipperer E, Germing U, Nollet F et al. High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600 \u00d7 109\/L) and ringed sideroblasts more than 15% considered as MDS\/MPD, unclassifiable. Blood 2007; 109: 1334\u20131335.","journal-title":"Blood"},{"key":"BFleu2011232_CR9","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010; 363: 2424\u20132433.","journal-title":"N Engl J Med"},{"issue":"7","key":"BFleu2011232_CR10","first-page":"a003707","volume":"3","author":"C. L. Will","year":"2010","unstructured":"Will CL, Luhrmann R . Spliceosome structure and function. Cold Spring Harb Perspect Biol 2011; 3: a.003707.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"BFleu2011232_CR11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.2649","volume":"220","author":"AJ Ward","year":"2010","unstructured":"Ward AJ, Cooper TA . The pathobiology of splicing. J Pathol 2010; 220: 152\u2013163.","journal-title":"J Pathol"},{"key":"BFleu2011232_CR12","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1001\/jama.2011.473","volume":"305","author":"DC Link","year":"2011","unstructured":"Link DC, Schuettpelz LG, Shen D, Wang J, Walter MJ, Kulkarni S et al. Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML. JAMA 2011; 305: 1568\u20131576.","journal-title":"JAMA"},{"key":"BFleu2011232_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/leu.2010.269","volume":"25","author":"A Pardanani","year":"2011","unstructured":"Pardanani A, Vannucchi AM, Passamonti F, Cervantes F, Barbui T, Tefferi A . JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations. Leukemia 2011; 25: 218\u2013225.","journal-title":"Leukemia"},{"key":"BFleu2011232_CR14","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/leu.2011.44","volume":"25","author":"MJ Walter","year":"2011","unstructured":"Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011; 25: 1153\u20131158.","journal-title":"Leukemia"},{"key":"BFleu2011232_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1182\/blood-2004-12-4649","volume":"106","author":"R Tehranchi","year":"2005","unstructured":"Tehranchi R, Invernizzi R, Grandien A, Zhivotovsky B, Fadeel B, Forsblom AM et al. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes. Blood 2005; 106: 247\u2013253.","journal-title":"Blood"},{"key":"BFleu2011232_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/ng.359","volume":"41","author":"DL Guernsey","year":"2009","unstructured":"Guernsey DL, Jiang H, Campagna DR, Evans SC, Ferguson M, Kellogg MD et al. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nat Genet 2009; 41: 651\u2013653.","journal-title":"Nat Genet"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2011232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011232","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:53:33Z","timestamp":1648738413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2011232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,2]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["BFleu2011232"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.232","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,2]]},"assertion":[{"value":"2 September 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}